• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚太地区的胆固醇、冠心病与中风

Cholesterol, coronary heart disease, and stroke in the Asia Pacific region.

作者信息

Zhang X, Patel A, Horibe H, Wu Z, Barzi F, Rodgers A, MacMahon S, Woodward M

出版信息

Int J Epidemiol. 2003 Aug;32(4):563-72. doi: 10.1093/ije/dyg106.

DOI:10.1093/ije/dyg106
PMID:12913030
Abstract

BACKGROUND

Cholesterol levels in many Asian countries are rising. Predictions of the likely effects of this on the incidence of cardiovascular diseases have mostly relied on data from Western populations. Whether the associations between total cholesterol and cardiovascular diseases are similar in Asia is not established.

METHODS

The Asia Pacific Cohort Studies Collaboration (APCSC) is an individual-participant data meta-analysis of prospective studies from the Asia-Pacific region. Cox models were applied to the combined data from 29 cohorts to estimate the region-, sex-, and age-specific hazard ratios of major cardiovascular diseases by the fifths of total cholesterol.

RESULTS

At baseline, the age/sex-adjusted mean value of total cholesterol was higher in Australia and New Zealand (ANZ) (5.52 +/- 1.05 mmol/l) than in Asia (4.87 +/- 1.05 mmol/l). During 2 million person-years of follow-up among 352 033 individuals, 4841 cardiovascular deaths were recorded. The association of total cholesterol with coronary heart disease and stroke was similar in Asian and ANZ cohorts. Overall, each 1-mmol/l higher level of total cholesterol was associated with 35% (95% CI: 26-44%) increased risk of coronary death, 25% (95% CI: 13-40%) increased risk of fatal or non-fatal ischaemic stroke, and 20% (95% CI: 8-30%) decreased risk of fatal haemorrhagic stroke.

CONCLUSIONS

In both Asian and non-Asian populations in the Asia-Pacific region, total cholesterol is similarly strongly associated with the risk of CHD and ischaemic, but not haemorrhagic, stroke. Rising population-wide levels of cholesterol would be expected to contribute to a substantial increase in the overall burden of cardiovascular diseases in this region.

摘要

背景

许多亚洲国家的胆固醇水平正在上升。关于这对心血管疾病发病率可能产生的影响的预测大多依赖于西方人群的数据。亚洲地区总胆固醇与心血管疾病之间的关联是否相似尚未明确。

方法

亚太队列研究协作组(APCSC)是一项对亚太地区前瞻性研究的个体参与者数据进行的荟萃分析。将Cox模型应用于29个队列的合并数据,以按总胆固醇五分位数估计主要心血管疾病在地区、性别和年龄方面的特定风险比。

结果

在基线时,澳大利亚和新西兰(ANZ)的年龄/性别调整后总胆固醇平均值(5.52±1.05 mmol/L)高于亚洲(4.87±1.05 mmol/L)。在352033名个体的200万人年随访期间,记录了4841例心血管死亡病例。亚洲和ANZ队列中总胆固醇与冠心病和中风的关联相似。总体而言,总胆固醇每升高1 mmol/L,冠心病死亡风险增加35%(95%CI:26 - 44%),致命或非致命缺血性中风风险增加25%(95%CI:13 - 40%),致命性出血性中风风险降低20%(95%CI:8 - 30%)。

结论

在亚太地区的亚洲和非亚洲人群中,总胆固醇与冠心病和缺血性中风(而非出血性中风)风险的关联同样强烈。预计该地区人群胆固醇水平的上升将导致心血管疾病总体负担大幅增加。

相似文献

1
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region.亚太地区的胆固醇、冠心病与中风
Int J Epidemiol. 2003 Aug;32(4):563-72. doi: 10.1093/ije/dyg106.
2
Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region.总胆固醇升高:亚太地区冠心病和缺血性卒中死亡的患病率及人群归因分数
Eur J Cardiovasc Prev Rehabil. 2008 Aug;15(4):397-401. doi: 10.1097/HJR.0b013e3282fdc967.
3
The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region.糖尿病对亚太地区主要心血管疾病风险及死亡的影响。
Diabetes Care. 2003 Feb;26(2):360-6. doi: 10.2337/diacare.26.2.360.
4
Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region.亚太地区收缩压和血清胆固醇对心血管疾病的联合影响。
Circulation. 2005 Nov 29;112(22):3384-90. doi: 10.1161/CIRCULATIONAHA.105.537472. Epub 2005 Nov 21.
5
Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region.亚太地区的胆固醇、糖尿病与主要心血管疾病
Diabetologia. 2007 Nov;50(11):2289-97. doi: 10.1007/s00125-007-0801-2. Epub 2007 Sep 25.
6
Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants.亚太地区的体重指数与心血管疾病:涉及310000名参与者的33个队列研究综述
Int J Epidemiol. 2004 Aug;33(4):751-8. doi: 10.1093/ije/dyh163. Epub 2004 Apr 22.
7
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.亚太地区血清甘油三酯作为心血管疾病的一个风险因素。
Circulation. 2004 Oct 26;110(17):2678-86. doi: 10.1161/01.CIR.0000145615.33955.83. Epub 2004 Oct 18.
8
Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study.非高密度脂蛋白胆固醇与日本一般人群冠心病和脑卒中亚型的发生:日山研究。
Atherosclerosis. 2014 Apr;233(2):343-348. doi: 10.1016/j.atherosclerosis.2014.01.005. Epub 2014 Jan 21.
9
A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia.亚洲和澳大拉西亚地区风险因素与心血管疾病之间关联的比较。
Eur J Cardiovasc Prev Rehabil. 2005 Oct;12(5):484-91. doi: 10.1097/01.hjr.0000170264.84820.8e.
10
A comparative analysis of risk factors and stroke risk for Asian and non-Asian men: the Asia Pacific cohort studies collaboration.亚洲和非亚洲男性的风险因素和中风风险的比较分析:亚太队列研究协作。
Int J Stroke. 2013 Dec;8(8):606-11. doi: 10.1111/ijs.12166. Epub 2013 Oct 22.

引用本文的文献

1
Statins and hemorrhagic stroke: New insight from a Mendelian randomization study.他汀类药物与出血性中风:孟德尔随机化研究的新见解。
Medicine (Baltimore). 2025 Aug 8;104(32):e43838. doi: 10.1097/MD.0000000000043838.
2
Modifiable Risk Factors for Stroke in Syria: A Nationwide Multi-centre Case-Control Study.叙利亚中风的可改变风险因素:一项全国性多中心病例对照研究。
Sci Rep. 2025 Jan 2;15(1):115. doi: 10.1038/s41598-024-83569-z.
3
High levels of blood lipid and glucose predict adverse prognosis in patients with aneurysmal subarachnoid hemorrhage.
高血脂和高血糖预示着动脉瘤性蛛网膜下腔出血患者的不良预后。
Heliyon. 2024 Sep 27;10(19):e38601. doi: 10.1016/j.heliyon.2024.e38601. eCollection 2024 Oct 15.
4
Explaining adverse cholesterol levels and distinct gender patterns in an Indonesian population compared with the U.S.解释与美国人群相比,印度尼西亚人群中不良胆固醇水平和不同性别模式的原因。
Econ Hum Biol. 2024 Aug;54:101403. doi: 10.1016/j.ehb.2024.101403. Epub 2024 May 25.
5
Lipid-Lowering Therapy and Hemorrhagic Stroke: A Never-Ending Debate of Clinical Implications. Have We Found the Answer?降脂治疗与出血性卒中:关于临床意义的无休止争论。我们找到答案了吗?
J Am Heart Assoc. 2024 Feb 20;13(4):e034099. doi: 10.1161/JAHA.124.034099. Epub 2024 Feb 7.
6
Dyslipidemia among Patients with Ischemic Stroke Admitted to the Department of Medicine of a Tertiary Care Centre.某三级医疗中心内科住院缺血性脑卒中患者的血脂异常情况。
JNMA J Nepal Med Assoc. 2023 Sep 1;61(265):718-722. doi: 10.31729/jnma.8261.
7
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.日本动脉粥样硬化协会(JAS)2022年动脉粥样硬化性心血管疾病预防指南。
J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19.
8
Identification of subgroups within a Japanese older adult population for whom statin therapy is effective in reducing mortality.确定日本老年人群体中的亚组,对于这些亚组人群,他汀类药物治疗可有效降低死亡率。
PLoS One. 2023 Dec 1;18(12):e0295052. doi: 10.1371/journal.pone.0295052. eCollection 2023.
9
Changes in total cholesterol level and cardiovascular disease risk among type 2 diabetes patients.2 型糖尿病患者总胆固醇水平变化与心血管疾病风险。
Sci Rep. 2023 May 23;13(1):8342. doi: 10.1038/s41598-023-33743-6.
10
Risk factors for stroke among anthropometric indices and lipid profiles in the Korean population: a large-scale cross-sectional study.韩国人群中体型指标和血脂谱与中风风险因素的相关性:一项大规模的横断面研究。
Sci Rep. 2023 Feb 20;13(1):2948. doi: 10.1038/s41598-023-29902-4.